Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / HIST1H2BF



This biomarker is also known as:
  • H2B/l,
  • H2B/a,
  • H2B histone family, member G,
  • histone H2B.1 A,
  • H2BFA,
  • H2B/k,
  • histone H2B.g,
  • H2BFL,
  • histone H2B type 1-C/E/F/G/I,
  • H2BFG,
  • H2BFK,
  • Histone H2B.g,
  • histone cluster 1, H2bf,
  • histone 1, H2bf,
  • H2BFH,
  • Histone H2B.h,
  • Histone H2B.k,
  • Histone H2B.l,
  • H2B/g,
  • H2B/h,
  • Histone H2B.a,
  • Histone H2B.1 A,

View in BioMuta


histone cluster 1, H2bf


QA State: Curated
Type: Gene
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: One
QA State: Curated


Performance Comment

Significance Analysis of Microarray (SAM) was used to develop a 7-gene classifier. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively This prognostic signature is closely associated with biochemical recurrence in patients after radical prostatectomy. The seven genes are: RRAGD, PQBP1, HIST1H2BC (HIST1H2BE, HIST1H2BF, HIST1H2BI), ALDH1A2, TRIM22, RBPMS, HSPB8.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.